Clinical trial
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
NCT00418522
Study timeline
Study start (unknown)2007-03-01Date precision: month
Registry last updated2026-08-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
Insulin glargineDRUG · verified · RxNorm: insulin glargine
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
DallasTexas, United States3HoustonTexas, United States2San AntonioTexas, United States2San DiegoCalifornia, United States2AtlantaGeorgia, United States1MiamiFlorida, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1Oklahoma CityOklahoma, United States1OmahaNebraska, United States1Las VegasNevada, United States1CharlotteNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00418522 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.